Oricula Therapeutics
Oricula Therapeutics develops and commercializes drugs to prevent hearing loss.
Oricula Therapeutics is active in the biotechnology, health care, therapeutics space based in Midwestern US, founded in 2013.
Within the biotechnology, health care, therapeutics space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Midwestern US.
The company is listed at the Grant stage of development.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $2M in funding.
| Sector | Biotechnology, Health Care, Therapeutics |
|---|---|
| Headquarters | Midwestern US |
| Founded | 2013 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $2,045,000 |
Website: oricularx.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account